ライフサイエンスコーパス: Klebsiella pneumoniae

1 erococcus faecium, and beta-lactam-resistant Klebsiella pneumoniae).

2 carbapenemase OXA-48, in lysate samples from Klebsiella pneumoniae.

3 human pathogens Streptococcus pneumoniae and Klebsiella pneumoniae.

4 ococcus faecium, Acinetobacter baumannii and Klebsiella pneumoniae.

5 verlapping AR genes, and are correlated with Klebsiella pneumoniae.

6 Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae.

7 orbactam-nonsusceptible, ompK36 porin mutant Klebsiella pneumoniae.

8 cus faecium (VRE), and beta-lactam-resistant Klebsiella pneumoniae.

9 ssues of infected mice by the human pathogen Klebsiella pneumoniae.

10 are also active against MDR E. coli and MDR Klebsiella pneumoniae.

11 o lung infection by the major human pathogen Klebsiella pneumoniae.

12 richia coli O157:H7, and multidrug resistant Klebsiella pneumoniae.

13 t within 4 h for Acinetobacter baumannii and Klebsiella pneumoniae.

14 eptible to infection by Escherichia coli and Klebsiella pneumoniae.

15 a variety of bacterial pathogens, including Klebsiella pneumoniae.

16 the rapid dissemination of a single clone of Klebsiella pneumoniae.

17 h diverse KPC producers not limited to ST258 Klebsiella pneumoniae.

18 ntibiotic-resistant metallo-beta-lactamase 1 Klebsiella pneumoniae.

19 in pathogenesis during bacteremia caused by Klebsiella pneumoniae.

20 for the vaccine against the K2 sero group of Klebsiella pneumoniae.

21 (MDR) strains of Salmonella Typhimurium and Klebsiella pneumoniae.

22 cture of an assembled T2SS from the pathogen Klebsiella pneumoniae.

23 jirovecii (18.8%), cytomegalovirus (15.6%), Klebsiella pneumoniae (15.6%), and Streptococcus pneumon

24 g-resistant Acinetobacter baumannii (52.2%), Klebsiella pneumoniae (22.4%), and Staphylococcus aureus

25 The most common baseline pathogens were Klebsiella pneumoniae (25.6%) and Pseudomonas aeruginosa

26 a pathogen (409/549 [74.5%]), predominantly Klebsiella pneumoniae (289/409 [70.1%]).

27 d intention-to-treat population (n=355) were Klebsiella pneumoniae (37%) and Pseudomonas aeruginosa (

28 The most frequent organism was Klebsiella pneumoniae (375 [86%] of 437; 291 [85%] of 34

29 the most common contributory pathogens were Klebsiella pneumoniae (86 [31%]), Streptococcus pneumoni

30 coli (28%), Burkholderia pseudomallei (11%), Klebsiella pneumoniae (9%), and Staphylococcus aureus (6

31 thod was as follows; Escherichia coli, 100%; Klebsiella pneumoniae, 92.9%; Klebsiella oxytoca, 95.5%;

32 Klebsiella pneumoniae, a bacterial pathogen that has acq

33 Klebsiella pneumoniae, a chief cause of nosocomial pneum

34 Klebsiella pneumoniae, a Gram-negative bacterium, is not

35 I agents, and multidrug-resistant strains of Klebsiella pneumoniae, a leading HAI agent, have caused

36 as historically largely been associated with Klebsiella pneumoniae, a predominant plasmid (pKpQIL), a

37 CutC GRE and the activating enzyme CutD from Klebsiella pneumoniae, a representative of the human mic

38 anavalin, Pichia pastoris lysyl oxidase, and Klebsiella pneumoniae acetolactate synthase.

39 rum activity, encompassing Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomon

40 beta-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

41 Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

42 Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

43 p., Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

44 Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

45 In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropene

46 nterobacteriaceae isolates, 125 (94.7%) were Klebsiella pneumoniae and 74 harbored K. pneumoniae carb

47 ogens Escherichia coli, Salmonella enterica, Klebsiella pneumoniae and Acinetobacter baumannii agains

48 e Neisseria gonorrhoeae datasets, as well as Klebsiella pneumoniae and Acinetobacter baumannii datase

49 y concentration values for Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.

50 linical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli.

51 bly identified pathogenic bacteria (that is, Klebsiella pneumoniae and Enterobacter cloacae) and thei

52 l rise in antimicrobial resistance (AMR) are Klebsiella pneumoniae and Enterobacter cloacae.

53 Klebsiella pneumoniae and Escherichia coli are part of t

54 ptococus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli in Conjunctiv

55 on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European h

56 Klebsiella pneumoniae and Escherichia coli were recovere

57 terferes with their cognate function against Klebsiella pneumoniae and Escherichia coli; vi) MAIT cel

58 s were detected from NP/OP specimens whereas Klebsiella pneumoniae and Mycobacterium tuberculosis wer

59 (-/-) mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis.

60 sortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae) has

61 obacteriaceae, including multidrug-resistant Klebsiella pneumoniae and pathogenic Escherichia coli, r

62 ainst Enterococcus faecium, platinum against Klebsiella pneumoniae and platinum and silver against Ac

63 Klebsiella pneumoniae and Pseudomonas aeruginosa are mic

64 y pathogens such as Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa.

65 d extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Salmonella typhimurium.

66 as Escherichia coli (ybaM), Dickeya solani, Klebsiella pneumoniae and Shigella flexneri.

67 e species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli .

68 . aureus], 2 Stenotrophomonas maltophilia, 1 Klebsiella pneumoniae) and resulted in antimicrobial cha

69 ith wound infections: Staphylococcus aureus, Klebsiella pneumoniae, and Acinetobacter baumannii.

70 n Escherichia coli, Pseudomonas syringae and Klebsiella pneumoniae, and endogenous CRISPR-Cas use was

71 , Clostridium perfringens, Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis.

72 omycin-resistant Enterococcus faecium (VRE), Klebsiella pneumoniae, and Escherichia coli in the intes

73 resistant Enterococcus, carbapenem-resistant Klebsiella pneumoniae, and Escherichia coli infection in

74 riggered by LPS from Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli Sixteen cyto

75 bacterium tuberculosis, Salmonella enterica, Klebsiella pneumoniae, and Escherichia coli We compare p

76 nt strains, such as Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli.

77 esistant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus spp.

78 of Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa We the

79 Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were t

80 cies-Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa-report

81 , Enterococcus faecalis, Klebsiella oxytoca, Klebsiella pneumoniae, and Staphylococcus aureus at age

82 ucosal challenge with the pulmonary pathogen Klebsiella pneumoniae, and substantially reduced epithel

83 Nosocomial infections with Klebsiella pneumoniae are a frequent cause of Gram-negat

84 DM)-producing strains of multidrug-resistant Klebsiella pneumoniae are a global public health threat

85 Escherichia coli and Klebsiella pneumoniae are opportunistic pathogens that a

86 , Micrococcus luteus, Bacillus subtilis, and Klebsiella pneumoniae at a minimal inhibitory concentrat

87 trains, notably against multi-drug resistant Klebsiella pneumoniae ATCC 700603 while isolates LB4 and

88 922, E. coli ATCC 35218, E. coli NCTC 13353, Klebsiella pneumoniae ATCC 700603, and Pseudomonas aerug

89 was hospitalized with septic shock caused by Klebsiella pneumoniae bacteremia.

90 ein A (TTPA) is a structural tail protein of Klebsiella pneumoniae bacteriophage KP32, and is respons

91 resistant (MDR) carbapenemase-producing (CP) Klebsiella pneumoniae, belonging to clonal group CG258,

92 oteins from E. coli, Salmonella enterica and Klebsiella pneumoniae bind c-di-GMP via the domain of un

93 t SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithe

94 ridium perfringens, Ruminococcus gnavus, and Klebsiella pneumoniae, but also beneficial species, such

95 portant carbapenem-resistant human pathogen, Klebsiella pneumoniae, by B. bacteriovorus in human seru

96 CPOs carrying the Klebsiella pneumoniae carbapenemase (bla KPC ) gene have

97 CAZ-AVI displays in vitro activity against Klebsiella pneumoniae carbapenemase (KPC) enzyme produce

98 detection of ertapenem (ETP) resistance and Klebsiella pneumoniae carbapenemase (KPC) in 47 Klebsiel

99 Klebsiella pneumoniae carbapenemase (KPC) is a widesprea

100 ogy labs to perform confirmatory testing for Klebsiella pneumoniae carbapenemase (KPC) production or

101 Imipenemase (IMP), Klebsiella pneumoniae carbapenemase (KPC), and Verona in

102 n of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhib

103 In the United States, Klebsiella pneumoniae carbapenemase (KPC)-producing Ente

104 Two clinical strains of Klebsiella pneumoniae carbapenemase (KPC)-producing K. p

105 oncerning is the widespread dissemination of Klebsiella pneumoniae carbapenemase (KPC).

106 tam antibiotics due to the production of the Klebsiella pneumoniae carbapenemase (KPC-2) class A beta

107 nce to their genotypic profiles, whereas all Klebsiella pneumoniae carbapenemase (KPC; n = 8) and GES

108 n with an Enterobacter sp. isolate producing Klebsiella pneumoniae Carbapenemase-4 and New Delhi Meta

109 Klebsiella pneumoniae carbapenemase-producing Enterobact

110 the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumon

111 Vancomycin-resistant enterococci and Klebsiella pneumoniae carbapenemase-producing K. pneumon

112 the emergence and clinical impact of a novel Klebsiella pneumoniae carbapenemase-producing K. pneumon

113 e performed on isolates to identify specific Klebsiella pneumoniae carbapenemases (KPC) and additiona

114 e, in contrast to metallo-beta-lactamases or Klebsiella pneumoniae carbapenemases (KPC), no specific

115 Klebsiella pneumoniae carbapenemases (KPCs) were first i

116 Klebsiella pneumoniae carbapenemases (KPCs) were origina

117 em-resistant Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemases.

118 Klebsiella pneumoniae carriage frequencies were estimate

119 We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope an

120 Klebsiella pneumoniae causes a wide range of infections,

121 Klebsiella pneumoniae causes pneumonia and liver abscess

122 Klebsiella pneumoniae causes severe lung and bloodstream

123 Klebsiella pneumoniae causing community-acquired pyogeni

124 teriaceae, primarily involving KPC-producing Klebsiella pneumoniae clonal complex CC258.

125 fecal material, resulting in eradication of Klebsiella pneumoniae compared with nonresponders.

126 cy, lung disease, baseline urine source, and Klebsiella pneumoniae, compared to the Escherichia coli

127 ial activity against E. coli, Salmonella and Klebsiella pneumoniae, comparing to the supercritical ex

128 am-negative bacteria on clinical isolates of Klebsiella pneumoniae, containing highly-resistant antim

129 istent with regional clinical concern, e.g., Klebsiella pneumoniae contigs containing KPC-2 within an

130 of infections caused by carbapenem-resistant Klebsiella pneumoniae continues to be challenging.

131 Infections caused by carpabenem-resistant Klebsiella pneumoniae (CR-Kp) are especially problematic

132 rgently needed to treat carbapenem-resistant Klebsiella pneumoniae (CR-Kp)-mediated infection, which

133 sortium on Resistance against Carbapenems in Klebsiella pneumoniae (CRACKLE) was constructed of patie

134 The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a major public h

135 k of OXA-232-expressing carbapenem-resistant Klebsiella pneumoniae (CRKP) transmitted to 16 patients

136 e growing importance of carbapenem-resistant Klebsiella pneumoniae (CRKP), the clonal relationships b

137 or infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKp).

138 nding global distribution of multi-resistant Klebsiella pneumoniae demands faster antimicrobial susce

139 Here we show that mice infected with Klebsiella pneumoniae develop lung injury with accumulat

140 te the antagonism between the microbiota and Klebsiella pneumoniae during colonization and transmissi

141 nterococcus faecium and carbapenem-resistant Klebsiella pneumoniae, emerge from the intestinal lumen

142 The most common CRE species were Klebsiella pneumoniae, Enterobacter aerogenes, and Esche

143 Klebsiella pneumoniae, Escherichia coli, and other membe

144 ta that produces SCFAs enhances clearance of Klebsiella pneumoniae, Escherichia coli, and Proteus mir

145 of antibiotic-resistant clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Proteus mir

146 a, Proteus mirabilis, Enterococcus faecalis, Klebsiella pneumoniae, Escherichia coli, and Staphylococ

147 0.7%, respectively, caused by ESBL-producing Klebsiella pneumoniae, Escherichia coli, Klebsiella oxyt

148 scovery of a new enzyme, first identified in Klebsiella pneumoniae from a patient from New Delhi and

149 seudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae from resin-containing BacT/Alert F

150 riable regions V3 and V6 were amplified from Klebsiella pneumoniae genomic DNA with blood in situ.

151 teria (Pseudomonas aeruginosa, 16-32 mug/mL, Klebsiella pneumoniae > 32 mug/mL).

152 Klebsiella pneumoniae harboring blaKPC (KPC-Kpn) is ende

153 nst clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to su

154 Klebsiella pneumoniae has a reputation for causing a wid

155 Carbapenemase-producing Klebsiella pneumoniae has become a global priority, not

156 idrug resistant (MDR) opportunistic pathogen Klebsiella pneumoniae has previously been shown to adapt

157 activity against Acinetobacter baumannii and Klebsiella pneumoniae; however, analogue 9 and 16 at 4 m

158 spiked with approximately 1,500 CFU bla(KPC) Klebsiella pneumoniae; however, the detection rate dropp

159 ly studied in some enteric bacteria, such as Klebsiella pneumoniae; however, their role in pathogenes

160 minant siderophore produced by hypervirulent Klebsiella pneumoniae (hvKP) and was previously shown to

161 New hypervirulent variants of Klebsiella pneumoniae (hvKP) are emerging globally, most

162 Hypervirulent Klebsiella pneumoniae (hvKP) is an emerging pathotype th

163 Hypervirulent Klebsiella pneumoniae (hvKp) is globally disseminating a

164 Hypervirulent (hypermucoviscous) Klebsiella pneumoniae (hvKP) strains are an emerging var

165 lly track a clonal outbreak of blaKPC-pKpQIL-Klebsiella pneumoniae in a proof-of-principle study.

166 ogues with in vivo efficacy against MRSA and Klebsiella pneumoniae in animal models of infection.

167 a17 cell numbers in vivo, we used a model of Klebsiella pneumoniae in mice deficient in STAT6.

168 the major uropathogens Proteus mirabilis and Klebsiella pneumoniae, in addition to UPEC, in humans.

169 lipopolysaccharide transporter LptB2FG from Klebsiella pneumoniae, in which both LptF and LptG are c

170 so show that expression of Gam in E. coli or Klebsiella pneumoniae increases sensitivity to fluoroqui

171 d in vivo during pneumoseptic infection with Klebsiella pneumoniae, indicating its regulatory role in

172 or in combination with Escherichia coli- or Klebsiella pneumoniae-induced pneumonia.

173 electin participates in host defense against Klebsiella pneumoniae-induced pulmonary inflammation is

174 reported that host defense against pulmonary Klebsiella pneumoniae infection requires IL-22, which wa

175 zone to induce Paneth cell loss, followed by Klebsiella pneumoniae infection to induce intestinal inj

176 Carbapenem-resistant Klebsiella pneumoniae infections are increasingly preval

177 The increasing incidence of Klebsiella pneumoniae infections refractory to treatment

178 Klebsiella pneumoniae is a common cause of antibiotic-re

179 Klebsiella pneumoniae is a common cause of antimicrobial

180 Klebsiella pneumoniae is a common colonizer of the gastr

181 Klebsiella pneumoniae is a common respiratory pathogen,

182 Klebsiella pneumoniae is a Gram-negative bacterial patho

183 Klebsiella pneumoniae is a human pathogen, prominent in

184 Klebsiella pneumoniae is a human, animal, and environmen

185 Klebsiella pneumoniae is a major threat to public health

186 Klebsiella pneumoniae is a respiratory, blood, liver, an

187 Klebsiella pneumoniae is an etiologic agent of community

188 Klebsiella pneumoniae is an important human pathogen cau

189 Klebsiella pneumoniae is an important pathogen in the co

190 Multidrug-resistant Klebsiella pneumoniae is an increasing cause of infant m

191 Klebsiella pneumoniae is an opportunistic pathogen and l

192 omial infections due to carbapenem-resistant Klebsiella pneumoniae is increasing worldwide.

193 Klebsiella pneumoniae is now recognized as an urgent thr

194 Klebsiella pneumoniae is part of the healthy human micro

195 Klebsiella pneumoniae is the most clinically relevant sp

196 esequencing of three plasmids in a reference Klebsiella pneumoniae isolate demonstrated approximately

197 g-resistant, carbapenemase (KPC-3)-producing Klebsiella pneumoniae isolate.

198 Klebsiella pneumoniae isolated from screening swabs and

199 Escherichia coli, Pseudomonas aeruginosa, or Klebsiella pneumoniae) isolated from clinical cases.

200 ion of long- and short-read sequence data of Klebsiella pneumoniae isolates (n = 1,717) from a Europe

201 0% of Escherichia coli isolates and 24.2% of Klebsiella pneumoniae isolates globally, with rates reac

202 ically-related NDM-1 carbapenemase producing Klebsiella pneumoniae isolates identified during an outb

203 bsiella pneumoniae carbapenemase (KPC) in 47 Klebsiella pneumoniae isolates using a novel automated m

204 tamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated.

205 were found among the Enterobacterales (for 2 Klebsiella pneumoniae isolates).

206 prim-resistant clinical Escherichia coli and Klebsiella pneumoniae isolates, suggesting that they may

207 (1) urine cultures growing Escherichia coli, Klebsiella pneumoniae, K. oxytoca, or Proteus mirabilis

208 Klebsiella pneumoniae K1 is a major agent of hepatic abs

209 428) and 9,371 isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus m

210 after this death phase, only three species, Klebsiella pneumoniae, Klebsiella oxytoca, and Providenc

211 (1) urine cultures growing Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, or Proteus mi

212 -/-) mice were infected intratracheally with Klebsiella pneumoniae (KP) and assessed for extrapulmona

213 Carbapenem-resistance in Klebsiella pneumoniae (KP) sequence type ST258 is mediat

214 Two types of Klebsiella pneumoniae (KP) strains are currently emergin

215 Recently, in Klebsiella pneumoniae (Kp), PqqD and PqqE were shown to

216 57BL/6 mice inoculated with a lethal dose of Klebsiella pneumoniae (KP).

217 cells, during acute pneumonic infection with Klebsiella pneumoniae (KPn).

218 ne domain of the Outer membrane protein A of Klebsiella pneumoniae (KpOmpA).

219 Escherichia coli PI-7, blaCTX-M-15-positive Klebsiella pneumoniae L7, and blaOXA-48-positive E. coli

220 ei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneumoniae, Legionella pneumophila, Pseudomon

221 Here, we show the increased prevalence of Klebsiella pneumoniae lipopolysaccharide O2 serotype str

222 d in O-antigenic polysaccharides (OPSs) from Klebsiella pneumoniae lipopolysaccharides.

223 Klebsiella pneumoniae liver abscess (KLA) is emerging wo

224 Klebsiella pneumoniae liver abscess (KPLA) is prevalent

225 ential of bacteriophages in a mouse model of Klebsiella pneumoniae lobar pneumonia.

226 Here we report the crystal structure of Klebsiella pneumoniae LpxH in complex with AZ1.

227 Carbapenem-resistant Klebsiella pneumoniae, most notably isolates classified

228 For Klebsiella pneumoniae, Mycobacterium tuberculosis, Salmo

229 ase genes were most frequently identified in Klebsiella pneumoniae (n = 1,127), Escherichia coli (n =

230 Klebsiella pneumoniae (n = 180, 41.9%), Escherichia coli

231 genes were detected by the Carba-R assay in Klebsiella pneumoniae (n = 236), Escherichia coli (n = 2

232 mmunities consisting of Escherichia coli and Klebsiella pneumoniae once antibiotics were removed.

233 1%) of 5332 E coli isolates, 13 (<1%) of 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter clo

234 ns and no ongoing outbreak of ESBL-producing Klebsiella pneumoniae or Enterobacter spp.

235 dministration of pathogenic bacteria, either Klebsiella pneumoniae or Salmonella enterica serovar Typ

236 ilis epsHIJK locus into pga-deleted E. coli, Klebsiella pneumoniae, or alginate-negative Pseudomonas

237 ter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca that were r

238 l isolates of either Pseudomonas aeruginosa, Klebsiella pneumoniae, or Staphylococcus aureus produces

239 (FMDV) veterinary outbreak in England and a Klebsiella pneumoniae outbreak in a Nepali neonatal unit

240 hese findings can help up better predict MDR Klebsiella pneumoniae outbreaks associated with specific

241 PS) of the multiresistant clinical strain of Klebsiella pneumoniae, PCM2713, and thus should be regar

242 radrenergic neurons improves survival during Klebsiella pneumoniae peritonitis (67 versus 23%, p < 0.

243 Klebsiella pneumoniae poses a major challenge to healthc

244 y resistant isolates of Escherichia coli and Klebsiella pneumoniae (PRIMERS I).

245 chia coli/Shigella spp., Klebsiella oxytoca, Klebsiella pneumoniae, Proteus spp., Pseudomonas aerugin

246 he Gram-negative pathogens Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acine

247 pathogens including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Esche

248 Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Esche

249 f Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphyloc

250 e-dependent protection of mice from a lethal Klebsiella pneumoniae pulmonary challenge.

251 the current epidemic of carbapenem-resistant Klebsiella pneumoniae rely on a comprehensive understand

252 Klebsiella pneumoniae remains an important cause of intr

253 Klebsiella pneumoniae resistance to third generation cep

254 A phenotype of Escherichia coli and Klebsiella pneumoniae, resistant to piperacillin/tazobac

255 The extracellular polysaccharide capsule of Klebsiella pneumoniae resists penetration by antimicrobi

256 , Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonellae typhi, Candida albica

257 ed susceptibility to Escherichia coli K1 and Klebsiella pneumoniae sepsis in antibiotic-treated neona

258 Carbapenem-resistant Klebsiella pneumoniae sequence type 258 (CRKP-ST258) can

259 t the capsular polysaccharide of a dominated Klebsiella pneumoniae serotype K2 is difficult to synthe

260 Here, we investigate the process in Klebsiella pneumoniae serotype O12 (and Raoultella terri

261 ainst SP-A- and SP-B(N)-resistant capsulated Klebsiella pneumoniae (serotype K2) at neutral pH.

262 The Klebsiella pneumoniae species complex includes important

263 Europe, carbapenem-resistant strains of the Klebsiella pneumoniae ST258 (ref.

264 ATCC 25922, CM-13457, and CM-10455) and one Klebsiella pneumoniae strain (CM-11073) were grown overn

265 For the rich mobilome of a hospital Klebsiella pneumoniae strain, circularization junctions

266 We previously isolated a Klebsiella pneumoniae strain, NTUH-K2044, from a communi

267 Carbapenem-resistant Klebsiella pneumoniae strains classified as multilocus s

268 ence of mcr-1 was investigated in E coli and Klebsiella pneumoniae strains collected from five provin

269 Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae

270 raperitoneally (i.p.) with Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae, lipopol

271 wk and then challenged intratracheally with Klebsiella pneumoniae, Streptococcus pneumoniae, or lipo

272 ed as model pJHCMW1, a plasmid isolated from Klebsiella pneumoniae that includes two beta-lactamase a

273 o human pathogens, Staphylococcus aureus and Klebsiella pneumoniae, that utilize this metal nutrient

274 umonic sepsis using pulmonary infection with Klebsiella pneumoniae, the expression of MGL1 was upregu

275 ing the sequence type 258 (ST258) lineage of Klebsiella pneumoniae There was very little evidence of

276 to killing by serum enhances the capacity of Klebsiella pneumoniae to cause infection, but it is an i

277 1 hypomorphic (Hypo) mice were infected with Klebsiella pneumoniae to determine infectious burden, im

278 survey of clinical polymyxin-resistant (PR) Klebsiella pneumoniae to determine the molecular mechani

279 zontal gene transfer (HGT) of blaOXA-48 from Klebsiella pneumoniae to Escherichia coli in an infected

280 acheally inoculated with either live or dead Klebsiella pneumoniae to induce either lung infection or

281 -derived sepsis caused by the human pathogen Klebsiella pneumoniae to study the role of platelets in

282 , as well as in a model of lung infection by Klebsiella pneumoniae Transferring serum from Ig-deficie

283 cation of DNA from Staphylococcus aureus and Klebsiella pneumoniae, two pathogens commonly related to

284 by encapsulated pathogens, there is still no Klebsiella pneumoniae vaccine available.

285 ) mice with the common human sepsis pathogen Klebsiella pneumoniae via the airways to induce pneumoni

286 teria could reduce bacterial burden in vivo, Klebsiella pneumoniae was injected into the tail veins o

287 Klebsiella pneumoniae was isolated from cattle, poultry,

288 Klebsiella pneumoniae was isolated from retail meats fro

289 Klebsiella pneumoniae was isolated from stool of 17/149

290 T CRE infection was identified in 59 (15.7%) Klebsiella pneumoniae was isolated in 83.2%; surgical si

291 sphoenolpyruvate carboxylase gene (ppc) from Klebsiella pneumoniae was overexpressed to access the on

292 netobacter baumannii and multidrug-resistant Klebsiella pneumoniae was treated with bacteriophages an

293 Enterococcus spp., Escherichia coli and Klebsiella pneumoniae were the common bacterial pathogen

294 studied the recovery of Escherichia coli and Klebsiella pneumoniae when exposed to meropenem, imipene

295 ndogenous endophthalmitis is associated with Klebsiella pneumoniae whereas Coagulase negative Staphyl

296 Inactivation of the apbE gene in Klebsiella pneumoniae, wherein the nqr operon and apbE a

297 coccus faecalis, Pseudomonas aeruginosa, and Klebsiella pneumoniae, which are frequently implicated i

298 subjected to intra-abdominal infection with Klebsiella pneumoniae, which results in liver injury and

299 During 2013, ST278 Klebsiella pneumoniae with blaNDM-7 was isolated from th

300 m negative bacteria (e.g., Escherichia coli, Klebsiella pneumoniae) with varying levels of antibiotic